Business
Notice of General Meeting
Notice of General Meeting.

About this update from Gunsynd Plc
[{"type":"text","content":"\n \nRNS Number : 2797Q Evocutis PLC 28 August 2014 \n \n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION\n \nEvocutis Plc\n(\"Evocutis\" or the \"Company\")\n \nProposed Capital Reorganisation\nProposed Subscription of 175,000,000 New Ordinary Shares at 0.12p\nNew Investing Policy\nNotice of General Meeting\n \nEvocutis Plc announces that it has today posted a circular (\"Circular\") to Shareholders containing a notice convening a general meeting of the Company (\"General Meeting\") to be held at 11 a.m. on 12 September 2014, at 200 Strand, London WC2R 1DJ. The Circular is available on the Company's website, at www.evocutis.com.\n \nThe Circular contains proposals (the \"Proposals\") for:\n \n· the Capital Reorganisation;\n· the proposed Subscription to raise £210,000; and\n· the adoption of a New Investing Policy under AIM Rule 15.\n \nSummary\nOn 13 March 2014, the Company passed a resolution to adopt an investing policy which became effective on 19 March 2014 when the Company completed the disposal of the intellectual property rights in LabskinTM and SYN1113 together with related equipment. The Company became an Investing Company from that date with its Existing Investing Policy. \nAlthough the Board has considered a number of opportunities within its Existing Investing Policy, it has come to the conclusion that the Existing Investing Policy may be unduly restrictive when considering suitable opportunities to create value for Shareholders. Therefore, the Board has resolved to expand the Company's investing policy in order to potentially maximise Shareholder value by adopting the New Investing Policy, and appoint, conditional upon Admission, two new directors, and raise further funding by way of the Subscription to enable the Company to make investments.\nFor further information, please contact:\n\n\n\n\nEvocutis plc\n\n\n \n\n\n\n\nTom Bannatyne, Chairman\n\n\n+44 (0)844 209 8440\n\n\n\n\nDr Gwyn Humphreys, Interim Chief Executive Officer\n\n\nwww.evocutis.com\n\n\n\n\n \n\n\n\n\nCairn Financial Advisers LLP\n\n\n \n\n\n\n\nJames Caithie/Carolyn ...